We are live on ! Find out more
CCA

Catalyst Capital Advisors Portfolio holdings

AUM $6.03B
1-Year Est. Return 24.5%
This Fund
S&P 500
This Quarter Est. Return
+14.93%
1 Year Est. Return
+24.5%
3 Year Est. Return
+62.66%
5 Year Est. Return
+62.45%
10 Year Est. Return
+241.55%
AUM
$2.87B
AUM Growth
+$187M
Cap. Flow
-$176M
Cap. Flow %
-6.14%
Top 10 Hldgs %
64.21%
Holding
508
New
96
Increased
109
Reduced
110
Closed
117

Top Buys

Rank Stock Value
1
AFL icon
Aflac
AFL
+$17.3M
2
A icon
Agilent Technologies
A
+$12.8M
3
WOLF icon
Wolfspeed
WOLF
+$11.1M
4
SPR
Spirit AeroSystems
SPR
+$8.74M
5
PG icon
Procter & Gamble
PG
+$7.3M

Top Sells

Rank Stock Value
1
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$32.4M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$27.8M
3
AMGN icon
Amgen
AMGN
+$22.1M
4
VB icon
Vanguard Small-Cap ETF
VB
+$18.3M
5
AXP icon
American Express
AXP
+$16.2M

Sector Composition

Rank Sector Weight
1 Energy 7.81%
2 Technology 4.09%
3 Healthcare 3.02%
4 Industrials 2.34%
5 Consumer Discretionary 2.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GNFT
326
DELISTED
Genfit
GNFT
$7K ﹤0.01%
+272
New +$6.28K
GPN icon
327
Global Payments
GPN
$22.1B
$7K ﹤0.01%
50
-150
-75% -$18.2K
JBGS
328
JBG SMITH
JBGS
$846M
$7K ﹤0.01%
179
+25
+16% +$981
LEVI icon
329
Levi Strauss
LEVI
$9.44B
$7K ﹤0.01%
+300
New +$6.72K
MGTX icon
330
MeiraGTx Holdings
MGTX
$1.09B
$7K ﹤0.01%
395
– –
NGVT icon
331
Ingevity
NGVT
$2.55B
$7K ﹤0.01%
68
+15
+28% +$1.51K
ORC
332
Orchid Island Capital
ORC
$1.31B
$7K ﹤0.01%
+220
New +$7.51K
REZI icon
333
Resideo Technologies
REZI
$5.23B
$7K ﹤0.01%
340
-232
-41% -$5.14K
TIGR
334
UP Fintech Holding
TIGR
$845M
$7K ﹤0.01%
+550
New +$6.44K
COUP
335
DELISTED
Coupa Software Incorporated
COUP
$7K ﹤0.01%
82
– –
MITO
336
DELISTED
Stealth BioTherapeutics Corp. ADS
MITO
$7K ﹤0.01%
+568
New +$7.64K
PLAN
337
DELISTED
Anaplan, Inc.
PLAN
$7K ﹤0.01%
180
+15
+9% +$505
CTK
338
DELISTED
CooTek (Cayman) Inc. American Depositary Shares, each representing 650 Class A Ordinary Shares
CTK
$7K ﹤0.01%
47
– –
KLDO
339
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$7K ﹤0.01%
+493
New +$6.79K
PRNB
340
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
$7K ﹤0.01%
210
– –
AMTB icon
341
Amerant Bancorp
AMTB
$1.12B
$6K ﹤0.01%
460
– –
BJ icon
342
BJs Wholesale Club
BJ
$11.9B
$6K ﹤0.01%
205
+30
+17% +$765
CCB icon
343
Coastal Financial
CCB
$1.1B
$6K ﹤0.01%
352
– –
DTIL icon
344
Precision BioSciences
DTIL
$188M
$6K ﹤0.01%
+12
New +$6.37K
MRNA icon
345
Moderna
MRNA
$21.5B
$6K ﹤0.01%
310
– –
NFE icon
346
New Fortress Energy
NFE
$101M
$6K ﹤0.01%
+500
New +$6.53K
NIU
347
Niu Technologies
NIU
$202M
$6K ﹤0.01%
795
– –
PFGC icon
348
Performance Food Group
PFGC
$17.5B
$6K ﹤0.01%
157
+20
+15% +$733
JF
349
J and Friends Holdings
JF
$15.5M
$6K ﹤0.01%
100
– –
STRO icon
350
Sutro Biopharma
STRO
$379M
$6K ﹤0.01%
50
– –
12 13
14
15 16

Similar funds

RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.03B AUM 40.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
GA
Greenhaven Associates Purchase, New York $6.07B AUM 11.2% 1-Year Est. Return

Catalyst Capital Advisors's Q1 2019 Portfolio in Review

As of Q1 2019, Catalyst Capital Advisors held 508 positions worth $2.87B, up 7% from $2.68B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Catalyst Capital Advisors withdrew a net $176M in Q1 2019, closing 117 positions and reducing 110 holdings. Its most notable exit was Amgen, an estimated $22.1M position sold in full.

By sector, the portfolio is most concentrated in Energy at 7.8% of assets, up from 6.1% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Catalyst Capital Advisors opened a new position in Aflac worth $18M.

  • Catalyst Capital Advisors's largest Q1 2019 buy was Aflac: 360,000 shares worth $18M.
  • Catalyst Capital Advisors added most to Agilent Technologies in Q1 2019, an estimated $12.8M increase.
  • Catalyst Capital Advisors's biggest Q1 2019 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $32.4M.
  • Catalyst Capital Advisors fully exited Amgen in Q1 2019, selling an estimated $22.1M.
  • Catalyst Capital Advisors's ten largest holdings make up 64% of its $2.87B portfolio in Q1 2019.
  • Catalyst Capital Advisors opened 96 new positions and closed 117 in Q1 2019.
  • Catalyst Capital Advisors's portfolio value rose 7% quarter-over-quarter to $2.87B.

Based on Catalyst Capital Advisors's 13F filing for Q1 2019, filed 8 May 2019.